Haddad RI - Search Results

1

Swallowing function following postchemoradiotherapy neck dissection: review of findings and analysis of contributing factors.

Chapuy CI, Annino DJ, Snavely A, Li Y, Tishler RB, Norris CM, Haddad RI, Goguen LA. Chapuy CI, et al. Among authors: haddad ri. Otolaryngol Head Neck Surg. 2011 Sep;145(3):428-34. doi: 10.1177/0194599811403075. Otolaryngol Head Neck Surg. 2011. PMID: 21493276 Free PMC article.

2

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience.

Haddad R, Colevas AD, Tishler R, Busse P, Goguen L, Sullivan C, Norris CM, Lake-Willcutt B, Case MA, Costello R, Posner M. Haddad R, et al. Cancer. 2003 Jan 15;97(2):412-8. doi: 10.1002/cncr.11063. Cancer. 2003. PMID: 12518365 Free article.

3

Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment.

Haddad R, Tishler RB, Norris CM, Mahadevan A, Busse P, Wirth L, Goguen LA, Sullivan CA, Costello R, Case MA, Posner MR. Haddad R, et al. Oncologist. 2003;8(1):35-44. doi: 10.1634/theoncologist.8-1-35. Oncologist. 2003. PMID: 12604730 Free article. Review.

4

Integration of chemotherapy in the curative treatment of locally advanced head and neck cancer.

Haddad RI, Wirth L, Posner MR. Haddad RI, et al. Expert Rev Anticancer Ther. 2003 Jun;3(3):331-8. doi: 10.1586/14737140.3.3.331. Expert Rev Anticancer Ther. 2003. PMID: 12820776 Review.

5

Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck.

Haddad R, Wirth L, Costello R, Weeks L, Posner M. Haddad R, et al. Semin Oncol. 2003 Dec;30(6 Suppl 18):84-8. doi: 10.1053/j.seminoncol.2003.11.011. Semin Oncol. 2003. PMID: 14727246 Clinical Trial.

6

Nonsurgical treatment of laryngeal cancer.

Haddad RI, Tishler RB, Posner MR. Haddad RI, et al. N Engl J Med. 2004 Mar 4;350(10):1049-53; author reply 1049-53. N Engl J Med. 2004. PMID: 15002117 No abstract available.

7

Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer.

McCollum AD, Burrell SC, Haddad RI, Norris CM, Tishler RB, Case MA, Posner MR, Van den Abbeele AD. McCollum AD, et al. Among authors: haddad ri. Head Neck. 2004 Oct;26(10):890-6. doi: 10.1002/hed.20080. Head Neck. 2004. PMID: 15390197

8

Endoscopic management of hypopharyngeal stenosis after organ sparing therapy for head and neck cancer.

Sullivan CA, Jaklitsch MT, Haddad R, Goguen LA, Gagne A, Wirth LJ, Posner MR, Tishler RB, Norris CM. Sullivan CA, et al. Laryngoscope. 2004 Nov;114(11):1924-31. doi: 10.1097/01.mlg.0000147921.74110.ee. Laryngoscope. 2004. PMID: 15510015

9

Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach.

Posner MR, Haddad RI, Wirth L, Norris CM, Goguen LA, Mahadevan A, Sullivan C, Tishler RB. Posner MR, et al. Among authors: haddad ri. Semin Oncol. 2004 Dec;31(6):778-85. doi: 10.1053/j.seminoncol.2004.09.007. Semin Oncol. 2004. PMID: 15599855 Review.

10

Chemoradiation-induced cell loss in human submandibular glands.

Sullivan CA, Haddad RI, Tishler RB, Mahadevan A, Krane JF. Sullivan CA, et al. Among authors: haddad ri. Laryngoscope. 2005 Jun;115(6):958-64. doi: 10.1097/01.MLG.0000163340.90211.87. Laryngoscope. 2005. PMID: 15933500

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters